<DOC>
	<DOCNO>NCT00074828</DOCNO>
	<brief_summary>LY517717 ( capsule give mouth ) blood thinner may prevent blood clot form leg may prevent blood clot travel lung . Leg lung blood clot occur commonly patient surgery replace hip knee joint . These clot often occur patient bed hospital hip knee joint surgery . The purpose study test different dose strength ( amount drug capsule ) LY517717 prevent blood clot form determine LY517717 safe . This study compare LY517717 enoxaparin , another blood thinner . Enoxaparin one standard medication give hip knee joint surgery .</brief_summary>
	<brief_title>New Oral Anticoagulant Therapy Prevention Blood Clots Following Hip Knee Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Are schedule total knee hip replacement surgery ( one side , first time joint replacement ) Are least 18 year age 75 year age . Have body weight 50 kg less 120 kg . Sign approve Eli Lilly Company inform consent document . Have hip knee replacement surgery nonsurgical leg surgical procedure surgical leg within 6 month prior enrollment . Other surgery ( brain , spinal cord , eye within 12 month ; chest abdominal surgery within 1 month ) . Have take drug might increase possibility bleeding . Other risk factor bleed ( bleed disorder , abnormal result blood test , ulcer ) Increased risk blood clot .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>elective</keyword>
	<keyword>primary unilateral</keyword>
</DOC>